ZA983089B - Sustained-release alginate gels - Google Patents

Sustained-release alginate gels

Info

Publication number
ZA983089B
ZA983089B ZA983089A ZA983089A ZA983089B ZA 983089 B ZA983089 B ZA 983089B ZA 983089 A ZA983089 A ZA 983089A ZA 983089 A ZA983089 A ZA 983089A ZA 983089 B ZA983089 B ZA 983089B
Authority
ZA
South Africa
Prior art keywords
sustained
alginate gels
release alginate
release
gels
Prior art date
Application number
ZA983089A
Other languages
English (en)
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of ZA983089B publication Critical patent/ZA983089B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
ZA983089A 1997-04-17 1998-04-14 Sustained-release alginate gels ZA983089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/842,756 US6656508B2 (en) 1997-04-17 1997-04-17 Sustained-release alginate gels

Publications (1)

Publication Number Publication Date
ZA983089B true ZA983089B (en) 1998-10-19

Family

ID=25288180

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983089A ZA983089B (en) 1997-04-17 1998-04-14 Sustained-release alginate gels

Country Status (13)

Country Link
US (1) US6656508B2 (xx)
EP (1) EP0975333B1 (xx)
JP (1) JP2001524084A (xx)
AT (1) ATE354351T1 (xx)
AU (1) AU6973498A (xx)
CA (1) CA2286092C (xx)
DE (1) DE69837140T2 (xx)
DK (1) DK0975333T3 (xx)
ES (1) ES2283052T3 (xx)
PT (1) PT975333E (xx)
TW (1) TW577755B (xx)
WO (1) WO1998046211A1 (xx)
ZA (1) ZA983089B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
DE69928472T2 (de) 1998-08-07 2006-08-10 Curis, Inc., Cambridge Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
RU2223782C2 (ru) * 1998-10-28 2004-02-20 Санкио Компани, Лимитед Средство для лечения патологического костного метаболизма
MXPA01007844A (es) * 1999-02-03 2005-06-06 Powderject Res Ltd Formulaciones de particulas en hidrogel.
CA2364198A1 (en) * 1999-03-08 2000-09-14 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2243497T3 (es) 2000-05-12 2005-12-01 PHARMACIA & UPJOHN COMPANY LLC Composicion de vacuna, procedimiento de preparacion de la misma y procedimiento para vacunacion de vertebrados.
EP1537860A1 (en) * 2000-05-12 2005-06-08 Pharmacia & Upjohn Company LLC Vaccine composition, method of preparing the composition and method of vaccinating vertebrates
US20030022856A1 (en) * 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
JP2003081865A (ja) * 2001-09-12 2003-03-19 Ltt Institute Co Ltd 水不溶性徐放性組成物、その製剤及びその製造方法
US20040005999A1 (en) * 2002-03-07 2004-01-08 Andreasen Kasper Huus Polyamino acid-based particle insulin preparation
US6840196B2 (en) 2002-03-13 2005-01-11 Aspen Pet Products, Inc. Rawhide pet chew
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US8112400B2 (en) * 2003-12-23 2012-02-07 Texas Instruments Incorporated Method for collecting data from semiconductor equipment
FI116625B (fi) * 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
US20080058410A1 (en) * 2004-07-23 2008-03-06 Dpi Solutions, Inc. Composition for Stabilizing Vitamin C in Water Phase and Method for Stabilizing C Using Thereof
CA2583308C (en) * 2004-10-08 2020-01-07 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
MX2007004261A (es) 2004-10-12 2007-06-18 Fmc Biopolymer As Sistemas de alginato auto-gelificantes y usos de los mismos.
US20060099550A1 (en) 2004-11-10 2006-05-11 Ranir/Dcp Corporation Device and method for delivering an oral care agent
ATE552032T1 (de) 2005-07-14 2012-04-15 Lithera Inc Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
WO2007146319A2 (en) * 2006-06-13 2007-12-21 Symphony Medical, Inc. Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
GB0624227D0 (en) * 2006-12-05 2007-01-10 Common Services Agency Protein purification
JP5162134B2 (ja) * 2007-01-22 2013-03-13 愛媛県 機能性材料の製造方法、機能性材料、シート状構造体、及び衛生製品
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
MX2010002328A (es) * 2007-08-28 2010-03-22 Fmc Corp Sistema de alginato de auto-gelatinizacion retardada y uso de los mismos.
SI2207568T1 (sl) 2007-11-16 2017-11-30 The Rockefeller University Protitelesa specifična za protifibrilno obliko beta-amiloidnega proteina
CA2756924A1 (en) * 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
JP2013517294A (ja) * 2010-01-15 2013-05-16 リセラ，インク． 凍結乾燥ケーキ製剤
CA2804842A1 (en) 2010-07-09 2012-01-12 Board Of Regents Of The University Of Texas System Biodegradable scaffolds
TW201231042A (en) 2010-11-24 2012-08-01 Lithera Inc Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
GB201120368D0 (en) 2011-11-24 2012-01-04 Sperm Vital As Methods for the preparation of hydrogels
CN103830266A (zh) * 2013-04-24 2014-06-04 杨亚勤 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用
WO2017027778A1 (en) 2015-08-13 2017-02-16 Temple University-Of The Commonwealth System Of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
EP4299072A3 (en) 2016-02-10 2024-05-01 Rutgers, the State University of New Jersey Novel anti-lam antibodies
EP3444612B1 (en) 2016-04-13 2022-03-23 LSI Medience Corporation Immunoassay employing sulfated polysaccharide
US10981976B2 (en) 2016-08-31 2021-04-20 University Of Rochester Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
WO2020045162A1 (ja) * 2018-08-30 2020-03-05 学校法人慶應義塾 薬物送達用担体

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507193A (en) 1949-05-17 1950-05-09 Bristol Lab Inc Penicillin product
US2882203A (en) 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
US2741573A (en) 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US3676557A (en) 1971-03-02 1972-07-11 Endo Lab Long-acting narcotic antagonist formulations
JPS5416979B2 (xx) 1972-01-08 1979-06-26
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4400391A (en) * 1980-01-09 1983-08-23 The United States Of America As Represented By The Secretary Of Agriculture Controlled release of bioactive materials using alginate gel beads
US4789516A (en) 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4695463A (en) 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
WO1990008551A1 (en) 1989-01-26 1990-08-09 Damon Biotech, Inc. Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5175093A (en) * 1989-11-07 1992-12-29 Lehigh University Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5837747A (en) * 1991-10-29 1998-11-17 Vivorx, Inc. Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5711968A (en) 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5451411A (en) * 1993-10-15 1995-09-19 University Of Washington Methods and compositions for the oral delivery of therapeutic agents
JPH10503179A (ja) 1994-06-24 1998-03-24 イミュネックス・コーポレーション 放出制御性ポリペプチド組成物および炎症性腸疾患の治療方法
US5629184A (en) 1995-01-25 1997-05-13 Amgen Inc. Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
ATE268591T1 (de) 1995-06-27 2004-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
AU2246097A (en) 1996-01-25 1997-08-20 Eli Lilly And Company Obesity protein analog compounds and formulations thereof
AU1838797A (en) 1996-02-06 1997-08-28 Eli Lilly And Company Obesity protein compounds and formulations thereof

Also Published As

Publication number Publication date
ES2283052T3 (es) 2007-10-16
EP0975333A1 (en) 2000-02-02
AU6973498A (en) 1998-11-11
PT975333E (pt) 2007-05-31
JP2001524084A (ja) 2001-11-27
US20020001619A1 (en) 2002-01-03
DE69837140T2 (de) 2007-11-29
ATE354351T1 (de) 2007-03-15
DK0975333T3 (da) 2007-06-18
CA2286092C (en) 2004-12-14
EP0975333B1 (en) 2007-02-21
DE69837140D1 (de) 2007-04-05
TW577755B (en) 2004-03-01
US6656508B2 (en) 2003-12-02
CA2286092A1 (en) 1998-10-22
WO1998046211A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
ZA983089B (en) Sustained-release alginate gels
ZA200006299B (en) Biodegradable sustained-release alginate gels.
WO1998051348A3 (en) Sustained-release delayed gels
ZA962135B (en) Conforming shoe construction and gel compositions therefor.
DE69326809D1 (de) Alginatgel
HUP9901714A3 (en) Polysaccharide gel composition
DK0784651T3 (da) Alginatgeler
BR9610156A (pt) Composição em gel
GB9403043D0 (en) Gel
GB2318814B (en) Foamable gel composition
EP0727462A3 (en) Silicone gel composition
GB2312824B (en) Quick-setting gel mix
GB9402992D0 (en) Gel
GB9704709D0 (en) Gels
ZA962728B (en) Podofilox gel formulation
ITAQ940003A0 (it) Idrogeli biocompatibili di alginati
SK49595A3 (en) Pectin gel as carrier of caffeine-coffee
GB9512125D0 (en) Gels
GB9502529D0 (en) Gels
GB9502519D0 (en) Gels
GB9509559D0 (en) Gel formulation
EP0663593A3 (en) Gel electrophoresis.